Literature DB >> 3395203

A structured interview guide for the Hamilton Depression Rating Scale.

J B Williams1.   

Abstract

The Hamilton Depression Rating Scale (HDRS) is the most widely used scale for patient selection and follow-up in research studies of treatments of depression. Despite extensive study of the reliability and validity of the total scale score, the psychometric characteristics of the individual items have not been well studied. In the only reliability study to report agreement on individual items using a test-retest interview method, most of the items had only fair or poor agreement. Because this is due in part to variability in the way the information is obtained to make the various rating distinctions, the Structured Interview Guide for the HDRS (SIGH-D) was developed to standardize the manner of administration of the scale. A test-retest reliability study conducted on a series of psychiatric inpatients demonstrated that the use of the SIGH-D results in a substantially improved level of agreement for most of the HDRS items.

Entities:  

Mesh:

Year:  1988        PMID: 3395203     DOI: 10.1001/archpsyc.1988.01800320058007

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  488 in total

1.  Influence of leisure activity on the incidence of Alzheimer's disease.

Authors:  N Scarmeas; G Levy; M X Tang; J Manly; Y Stern
Journal:  Neurology       Date:  2001-12-26       Impact factor: 9.910

2.  Morphological changes in subregions of hippocampus and amygdala in major depressive disorder patients.

Authors:  Zhijun Yao; Yu Fu; Jianfeng Wu; Wenwen Zhang; Yue Yu; Zicheng Zhang; Xia Wu; Yalin Wang; Bin Hu
Journal:  Brain Imaging Behav       Date:  2020-06       Impact factor: 3.978

3.  MRI signal hyperintensities and treatment remission of geriatric depression.

Authors:  Faith M Gunning-Dixon; Michael Walton; Janice Cheng; Jessica Acuna; Sibel Klimstra; Molly E Zimmerman; Adam M Brickman; Matthew J Hoptman; Robert C Young; George S Alexopoulos
Journal:  J Affect Disord       Date:  2010-05-07       Impact factor: 4.839

4.  Treatment of depression associated with age-related macular degeneration: a double-blind, randomized, controlled study.

Authors:  Barbara L Brody; Linda C Field; Anne-Catherine Roch-Levecq; Christine Y Moutier; Steven D Edland; Stuart I Brown
Journal:  Ann Clin Psychiatry       Date:  2011-11       Impact factor: 1.567

5.  The dependability of alliance assessments: the alliance-outcome correlation is larger than you might think.

Authors:  Paul Crits-Christoph; Mary Beth Connolly Gibbons; Jessica Hamilton; Sarah Ring-Kurtz; Robert Gallop
Journal:  J Consult Clin Psychol       Date:  2011-06

6.  Studying suicide with psychological autopsy: social and cultural feasibilities of the methodology in China.

Authors:  Jie Zhang; William F Wieczorek; Chao Jiang; Li Zhou; Shuhua Jia; Yueji Sun; Shenghua Jin; Yeates Conwell
Journal:  Suicide Life Threat Behav       Date:  2002

7.  The Relationship Between Childhood Trauma and Poor Sleep Health in Adulthood.

Authors:  Ryan C Brindle; Matthew R Cribbet; Laura B Samuelsson; Chenlu Gao; Ellen Frank; Robert T Krafty; Julian F Thayer; Daniel J Buysse; Martica H Hall
Journal:  Psychosom Med       Date:  2018 Feb/Mar       Impact factor: 4.312

8.  Intolerance of uncertainty: a common factor in the treatment of emotional disorders.

Authors:  James F Boswell; Johanna Thompson-Hollands; Todd J Farchione; David H Barlow
Journal:  J Clin Psychol       Date:  2013-02-04

9.  Efficacy and mood conversion rate during long-term fluoxetine v. lithium monotherapy in rapid- and non-rapid-cycling bipolar II disorder.

Authors:  Jay D Amsterdam; Lola Luo; Justine Shults
Journal:  Br J Psychiatry       Date:  2012-10-25       Impact factor: 9.319

10.  Psychotherapy credibility ratings: patient predictors of credibility and the relation of credibility to therapy outcome.

Authors:  Tessa Katherine Mooney; Mary Beth Connolly Gibbons; Robert Gallop; Rachel A Mack; Paul Crits-Christoph
Journal:  Psychother Res       Date:  2013-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.